Tango Therapeutics, Inc. - TNGX - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	25	8	37	25	37	42	62	54	📊
Revenue Growth (1Y)	--	-68.94%	+383.83%	-32.89%	+46.93%	+15.17%	+48.29%	-13.74%	📊
Revenue Growth (5Y)	--	--	--	--	+48.19%	+449.49%	+68.41%	+45.27%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	32	2	0	0	0	0	2	1	📊
Cost of Revenue Growth (1Y)	--	-94.96%	-100.00%	--	--	--	--	-58.70%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	-100.00%	-100.00%	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	-8	6	37	25	37	42	60	53	📊
Gross Profit Growth (1Y)	--	+179.10%	+514.19%	-32.89%	+46.93%	+15.17%	+42.87%	-12.04%	📊
Gross Profit Growth (5Y)	--	--	--	--	+579.04%	+597.55%	+62.26%	+42.73%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	8	58	95	136	151	188	171	189	📊
Operating Expenses Growth (1Y)	--	+672.60%	+63.54%	+42.74%	+10.87%	+24.53%	-8.67%	+10.40%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+1899.47%	+222.28%	+79.97%	+98.69%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	8	8	18	30	36	44	42	57	📊
Research and Development	32	50	78	106	115	144	132	134	📊
Other Income Expenses	-32	0	0	0	0	0	-2	-2	📊
EBITDA	-15	-50	-57	-107	-99	-128	-99	-127	📊
EBITDA Growth (1Y)	--	-246.77%	-13.31%	-86.72%	+6.87%	-28.63%	+22.17%	-27.61%	📊
EBITDA Growth (5Y)	--	--	--	--	-583.21%	-153.43%	-74.09%	-122.16%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	1	2	1	2	2	2	2	1	📊
Operating Income	-15	-52	-58	-111	-114	-146	-111	-136	📊
Operating Income Growth (1Y)	--	-244.28%	-11.48%	-90.88%	-2.79%	-27.52%	+23.56%	-22.52%	📊
Operating Income Growth (5Y)	--	--	--	--	-653.02%	-178.92%	-91.25%	-134.31%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	0	0	0	--	📊
Pre Tax Income	-14	-52	-58	-108	-102	-130	-102	-124	📊
Tax Provision	0	0	0	0	0	0	0	--	📊
NET INCOME	-14	-52	-58	-108	-102	-130	-102	-124	📊
Net Income Growth (1Y)	--	-268.73%	-12.05%	-85.76%	+5.95%	-28.07%	+22.03%	-21.78%	📊
Net Income Growth (5Y)	--	--	--	--	-621.84%	-150.72%	-74.46%	-112.45%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	-1.57	-1.62	-0.94	-1.23	-1.08	-1.19	-0.87	-0.85	📊
Diluted EPS	-1.57	-1.62	-0.94	-1.23	-1.08	-1.19	-0.87	-0.85	📊
Basic Average Shares	87	87	62	88	95	109	116	130	📊
Diluted Average Shares	87	87	62	88	95	109	116	130	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

-68.94%

+383.83%

-32.89%

+46.93%

+15.17%

+48.29%

-13.74%

📊

Revenue Growth (5Y)

+48.19%

+449.49%

+68.41%

+45.27%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-94.96%

-100.00%

-58.70%

📊

Cost of Revenue Growth (5Y)

-100.00%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-8

📊

Gross Profit Growth (1Y)

+179.10%

+514.19%

-32.89%

+46.93%

+15.17%

+42.87%

-12.04%

📊

Gross Profit Growth (5Y)

+579.04%

+597.55%

+62.26%

+42.73%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

136

151

188

171

189

📊

Operating Expenses Growth (1Y)

+672.60%

+63.54%

+42.74%

+10.87%

+24.53%

-8.67%

+10.40%

📊

Operating Expenses Growth (5Y)

+1899.47%

+222.28%

+79.97%

+98.69%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

106

115

144

132

134

📊

Other Income Expenses

-32

-2

📊

EBITDA

-15

-50

-57

-107

-99

-128

-99

-127

📊

EBITDA Growth (1Y)

-246.77%

-13.31%

-86.72%

+6.87%

-28.63%

+22.17%

-27.61%

📊

EBITDA Growth (5Y)

-583.21%

-153.43%

-74.09%

-122.16%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-15

-52

-58

-111

-114

-146

-111

-136

📊

Operating Income Growth (1Y)

-244.28%

-11.48%

-90.88%

-2.79%

-27.52%

+23.56%

-22.52%

📊

Operating Income Growth (5Y)

-653.02%

-178.92%

-91.25%

-134.31%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-14

-52

-58

-108

-102

-130

-102

-124

📊

Tax Provision

📊

NET INCOME

-14

-52

-58

-108

-102

-130

-102

-124

📊

Net Income Growth (1Y)

-268.73%

-12.05%

-85.76%

+5.95%

-28.07%

+22.03%

-21.78%

📊

Net Income Growth (5Y)

-621.84%

-150.72%

-74.46%

-112.45%

📊

Net Income Growth (10Y)

📊

Basic EPS

-1.57

-1.62

-0.94

-1.23

-1.08

-1.19

-0.87

-0.85

📊

Diluted EPS

-1.57

-1.62

-0.94

-1.23

-1.08

-1.19

-0.87

-0.85

📊

Basic Average Shares

109

116

130

📊

Diluted Average Shares

109

116

130

📊

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	25	8	37	25	37	42	62	54	📊
Revenue Growth (1Y)	--	-68.94%	+383.83%	-32.89%	+46.93%	+15.17%	+48.29%	-13.74%	📊
Revenue Growth (5Y)	--	--	--	--	+48.19%	+449.49%	+68.41%	+45.27%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	32	2	0	0	0	0	2	1	📊
Cost of Revenue Growth (1Y)	--	-94.96%	-100.00%	--	--	--	--	-58.70%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	-100.00%	-100.00%	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	-8	6	37	25	37	42	60	53	📊
Gross Profit Growth (1Y)	--	+179.10%	+514.19%	-32.89%	+46.93%	+15.17%	+42.87%	-12.04%	📊
Gross Profit Growth (5Y)	--	--	--	--	+579.04%	+597.55%	+62.26%	+42.73%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	8	58	95	136	151	188	171	189	📊
Operating Expenses Growth (1Y)	--	+672.60%	+63.54%	+42.74%	+10.87%	+24.53%	-8.67%	+10.40%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+1899.47%	+222.28%	+79.97%	+98.69%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	8	8	18	30	36	44	42	57	📊
Research and Development	32	50	78	106	115	144	132	134	📊
Other Income Expenses	-32	0	0	0	0	0	-2	-2	📊
EBITDA	-15	-50	-57	-107	-99	-128	-99	-127	📊
EBITDA Growth (1Y)	--	-246.77%	-13.31%	-86.72%	+6.87%	-28.63%	+22.17%	-27.61%	📊
EBITDA Growth (5Y)	--	--	--	--	-583.21%	-153.43%	-74.09%	-122.16%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	1	2	1	2	2	2	2	1	📊
Operating Income	-15	-52	-58	-111	-114	-146	-111	-136	📊
Operating Income Growth (1Y)	--	-244.28%	-11.48%	-90.88%	-2.79%	-27.52%	+23.56%	-22.52%	📊
Operating Income Growth (5Y)	--	--	--	--	-653.02%	-178.92%	-91.25%	-134.31%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	0	0	0	--	📊
Pre Tax Income	-14	-52	-58	-108	-102	-130	-102	-124	📊
Tax Provision	0	0	0	0	0	0	0	--	📊
NET INCOME	-14	-52	-58	-108	-102	-130	-102	-124	📊
Net Income Growth (1Y)	--	-268.73%	-12.05%	-85.76%	+5.95%	-28.07%	+22.03%	-21.78%	📊
Net Income Growth (5Y)	--	--	--	--	-621.84%	-150.72%	-74.46%	-112.45%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	-1.57	-1.62	-0.94	-1.23	-1.08	-1.19	-0.87	-0.85	📊
Diluted EPS	-1.57	-1.62	-0.94	-1.23	-1.08	-1.19	-0.87	-0.85	📊
Basic Average Shares	87	87	62	88	95	109	116	130	📊
Diluted Average Shares	87	87	62	88	95	109	116	130	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

-68.94%

+383.83%

-32.89%

+46.93%

+15.17%

+48.29%

-13.74%

📊

Revenue Growth (5Y)

+48.19%

+449.49%

+68.41%

+45.27%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-94.96%

-100.00%

-58.70%

📊

Cost of Revenue Growth (5Y)

-100.00%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-8

📊

Gross Profit Growth (1Y)

+179.10%

+514.19%

-32.89%

+46.93%

+15.17%

+42.87%

-12.04%

📊

Gross Profit Growth (5Y)

+579.04%

+597.55%

+62.26%

+42.73%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

136

151

188

171

189

📊

Operating Expenses Growth (1Y)

+672.60%

+63.54%

+42.74%

+10.87%

+24.53%

-8.67%

+10.40%

📊

Operating Expenses Growth (5Y)

+1899.47%

+222.28%

+79.97%

+98.69%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

106

115

144

132

134

📊

Other Income Expenses

-32

-2

📊

EBITDA

-15

-50

-57

-107

-99

-128

-99

-127

📊

EBITDA Growth (1Y)

-246.77%

-13.31%

-86.72%

+6.87%

-28.63%

+22.17%

-27.61%

📊

EBITDA Growth (5Y)

-583.21%

-153.43%

-74.09%

-122.16%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-15

-52

-58

-111

-114

-146

-111

-136

📊

Operating Income Growth (1Y)

-244.28%

-11.48%

-90.88%

-2.79%

-27.52%

+23.56%

-22.52%

📊

Operating Income Growth (5Y)

-653.02%

-178.92%

-91.25%

-134.31%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-14

-52

-58

-108

-102

-130

-102

-124

📊

Tax Provision

📊

NET INCOME

-14

-52

-58

-108

-102

-130

-102

-124

📊

Net Income Growth (1Y)

-268.73%

-12.05%

-85.76%

+5.95%

-28.07%

+22.03%

-21.78%

📊

Net Income Growth (5Y)

-621.84%

-150.72%

-74.46%

-112.45%

📊

Net Income Growth (10Y)

📊

Basic EPS

-1.57

-1.62

-0.94

-1.23

-1.08

-1.19

-0.87

-0.85

📊

Diluted EPS

-1.57

-1.62

-0.94

-1.23

-1.08

-1.19

-0.87

-0.85

📊

Basic Average Shares

109

116

130

📊

Diluted Average Shares

109

116

130

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	0.06%
Next Earnings
Market cap	3.26B (USD)
EPS (TTM)	-0.85 ($)
P/E (TTM)	-25.59 ($)
Last Close	21.75

Next Earnings
Market cap	3.26B (USD)
EPS (TTM)	-0.85 ($)
P/E (TTM)	-25.59 ($)
Last Close	21.75 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	0.06%
Next Earnings
Market cap	3.26B (USD)
EPS (TTM)	-0.85 ($)
P/E (TTM)	-25.59 ($)
Last Close	21.75

Next Earnings
Market cap	3.26B (USD)
EPS (TTM)	-0.85 ($)
P/E (TTM)	-25.59 ($)
Last Close	21.75 ($)